InvestorsHub Logo
Followers 65
Posts 23939
Boards Moderated 0
Alias Born 11/23/2016

Re: kld2 post# 276393

Friday, 10/16/2020 2:55:01 AM

Friday, October 16, 2020 2:55:01 AM

Post# of 462881
Very unlikely Dr. Missling would say in public that the 30mg and 50mg doses were both efficacious and significant as a dataless completely manufactured statement.

For whatever reason data was delayed beyond Anavex being able to PR the readout by end Q3. We got a topline statement yesterday before all the detailed and subgroup analysis is complete.

I did not dare to hope, based on A2-73 data to date and non before now in PDD, that both the 30mg and 50mg doses would contribute positively to the topline and am on record as expecting PR only after subgroup analysis.

Yes it is unusual to issue topline results completely without data, not even a single P value. Be it as it may, but shareholders have been screaming for PR probably not just here on iHub. Missling did say he wanted results out to shareholders immediately and that's what we got.

The market in analyst speak rightly had expectations of a little more colour on the 'great it works' PR. We saw that expressed in the price action yesterday (even when compensating for the Cabal effect).

Luckily for many an amount of de-risking occurred yesterday without the need to sell any shares.

PS! I am still here. Sorry not planning on going anywhere and haven't got anywhere near as many posts out as my target require. Will try to get some more AH one's out, but usually fall asleep.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News